Catholic Teaching on Stopping Cancer Treatment

It is rarely phrased as a question about moral theology. It is usually: if I say no to another line of treatment, am I doing something wrong? Often the person asking has already decided what they want and is looking for permission, or is afraid of what a priest, or a parent, or a spouse will say.

The teaching is more permissive than most people expect, and it has been settled for a long time.

The Ethical and Religious Directives, the norms that govern Catholic hospitals in the United States, put it this way in the seventh edition, approved by the US bishops in November 2025:

A person has a moral obligation to use ordinary/proportionate means of preserving his or her life. Proportionate means are those that offer a reasonable hope of benefit and do not entail an excessive burden or impose excessive expense on the patient, the family, or the community.

A person may forgo extraordinary/disproportionate means of preserving life.

So there are two categories. The first carries a duty. The second does not. Everything then turns on which category a particular treatment falls into for a particular person — and that is not a question with a universal answer, which is exactly why the teaching does not try to give one.

This is the part that surprises people, and the 2025 edition made it more explicit than before:

The final determination as to what constitutes a proportionate benefit and what constitutes an excessive burden belongs to the patient (or the patient's surrogate) and should be informed by professional medical advice.

Not the doctor. Not the family. Not the parish. The patient, informed by medical advice. The 1980 Vatican declaration on euthanasia said much the same thing decades earlier: the decision belongs "to the conscience either of the sick person, or of those qualified to speak in the sick person's name, or of the doctors."

The tradition is notably concrete about this. The 1980 declaration listed the things to weigh: "the type of treatment to be used, its degree of complexity or risk, its cost and the possibilities of using it, and comparing these elements with the result that can be expected, taking into account the state of the sick person and his or her physical and moral resources."

Cost appears on that list, and the 2025 Directives added the patient to the list of people who may bear excessive expense. Financial ruin is a legitimate consideration, not a shameful one.

The 1980 text also explicitly permits stopping something already started: "It is also permitted, with the patient's consent, to interrupt these means, where the results fall short of expectations." Beginning a treatment does not commit you to continuing it.

The same document addresses experimental treatment directly, and positively: where no other sufficient remedies exist, it is permitted, with consent, to use "the means provided by the most advanced medical techniques, even if these means are still at the experimental stage and are not without a certain risk," and it adds that in accepting them "the patient can even show generosity in the service of humanity."

Enrolling in a phase I trial is a recognized option, not a desperate act. So is withdrawing from one.

None of this permits acting in order to cause death. The distinction is intention. Evangelium Vitae, John Paul II's 1995 encyclical, draws it carefully:

Euthanasia must be distinguished from the decision to forego so-called "aggressive medical treatment", in other words, medical procedures which no longer correspond to the real situation of the patient... To forego extraordinary or disproportionate means is not the equivalent of suicide or euthanasia; it rather expresses acceptance of the human condition in the face of death.

The 2020 Vatican letter Samaritanus bonus restated it and added a caution in the other direction: "The suspension of futile treatments must not involve the withdrawal of therapeutic care." Stopping cancer-directed treatment is not stopping care. Symptom control, nursing, hydration where it still helps, and human presence continue.

The Directives make the same point about resuscitation orders in a footnote worth quoting to anyone who is uneasy about signing one: "It must be clear to patients, families, and caregivers that a DNAR order does not mean that ongoing care should cease; on the contrary, ordinary/proportionate care should continue."

The introduction to the end-of-life section of the Directives names both failure modes, which is unusual and useful:

In this way two extremes are avoided: on the one hand, an insistence on likely ineffective or burdensome interventions even when a patient may legitimately wish to forgo them; and, on the other hand, the withdrawal or application of interventions with the intention of causing death.

Families under pressure usually only fear the second. The first is the one that quietly happens more often in oncology.

It cannot tell you whether a particular treatment is proportionate for you. That judgment needs your diagnosis, your prognosis as your team understands it, your goals, and your circumstances. What it can tell you is that the judgment is genuinely yours to make, that the tradition expects you to make it, and that a decision to stop is not, by itself, a decision to die.

If you want help thinking it through, ask the hospital for a chaplain and for an ethics consultation. Both are free, both are used to these conversations, and neither requires you to have made up your mind first.